Loading data…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$26.97M net loss for the year ended February 1, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| February 3, 2025 – February 1, 2026 | $278,139,000 | April 17, 2026 | 10-K ↗ |
| January 29, 2024 – February 2, 2025 | $317,357,000 | April 17, 2026 | 10-K ↗ |
| January 30, 2023 – January 28, 2024 | $344,645,000 | April 17, 2026 | 10-K ↗ |
| January 31, 2022 – January 29, 2023 | $583,102,000 | April 18, 2025 | 10-K ↗ |
| February 1, 2021 – January 30, 2022 | $593,612,000 | April 12, 2024 | 10-K ↗ |
| February 3, 2020 – January 31, 2021 | $540,081,000 | April 14, 2023 | 10-K ↗ |
| February 4, 2019 – February 2, 2020 | $610,824,000 | April 15, 2022 | 10-K ↗ |
| January 29, 2018 – February 3, 2019 | $683,501,000 | April 16, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · Retrieved October 15, 2026
Response SHA-256: e0312e004e50382ce42685b8b952408a6fcb90969d18d5a646ab3dbf63debd85
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.